Improving Prenatal Care for Preeclampsia Prevention

This study is looking at a new way to provide prenatal care called Centering HER. It combines regular prenatal care with seven virtual group sessions led by a doula (a trained support person for pregnant individuals) and oversight from an OB/GYN doctor. You would also use a Bluetooth blood pressure cuff and scale at home, and possibly an Apple Watch. The goal is to see if Centering HER helps pregnant individuals monitor their blood pressure and take aspirin as prescribed, which could reduce the risk of early-onset preeclampsia (a serious blood pressure condition during pregnancy). This study is for pregnant individuals who are less than 13 weeks pregnant, aged 18 to 45, speak English or Spanish, and have a moderate or high risk for high blood pressure during pregnancy.

Study design
This is an interventional study with 36 participants. You would be randomly assigned to either receive Centering HER or usual doula care.
What's involved
If assigned to Centering HER, you would attend 7 virtual group sessions and self-monitor/report your blood pressure and weight. You would also complete surveys at the beginning, during, and after pregnancy.
Compensation
Not stated in the trial record.
Follow-up
Your blood pressure will be measured from enrollment until the end of treatment at 12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07491510

Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income

Enrolling by Invitation
NAAges 18–45InterventionalPrevention
University of Kansas Medical Center
~36 participants
Updated 2026-07-07 on ClinicalTrials.gov
What's tested:Active Comparator: Behavioral: Experimental: Centering HER (routine prenatal care + 7 doula-led 90-minute virtual group

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
mean diastolic blood pressure
Measured over From enrollment to the end of treatment at 12 weeks
+1 more outcome measured
Monitoring Blood Pressure
Aspirin Prophylaxis
1 sites across 1 states
Kansas1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English or Spanish speaking
\<13 weeks gestations
\>18 years old
moderate or high risk for hypertensive disorders in pregnancy

Exclusion

less than18 years of age
not receiving prenatal care
not eligible for doula care
no risk factors for hypertensive disorders in pregnancy
  • mean diastolic blood pressureFrom enrollment to the end of treatment at 12 weeks

    Average daily diastolic blood pressure

  • mean systolic blood pressureFrom enrollment of study to end of treatment at 12 weeks

    Average daily systolic blood pressure